Eahm2019 | Bart Vannieuwenhuyse - Big Data and its added value in…

28th Congress of the European Association for hospital managers

Mr. Vannieuwenhuyse Bart

Janssen Pharmaceutica Data Sciences Lead Benelux Campus

Big data & digital health

Big Data and its added value in clinical research

Bart Vannieuwenhuyse is Senior Director Health Information Sciences at Janssen, Pharmaceutical Companies of Johnson and Johnson. He joined Janssen Pharmaceutica as a clinical trial monitor in 1985. In the course of his career with Janssen, Bart has held a variety of marketing and sales positions, both at local operating company level (e.g. the Netherlands) and at international level. While in the Netherlands he was one of the pioneers that started “Healthy Solutions” a J&J daughter company that focused on developing integrated services in the healthcare field. Later, he was in the core team that developed the initial CRM approach for Janssen EMEA. Between 1999 and 2003, Bart spent 4 years in the IM department of Janssen Pharmaceutica in the US, where he was responsible for the e-business initiatives and for the overall IM technical architecture. Bart joined the EMEA CRM Center of Excellence in April 2003, where he prepared the CRM Roadmap for the short to mid-term. In 2009 Bart was instrumental in developing a new customer-orientation project for Janssen Europe. In 2011 Bart joined the Janssen R&D group to focus on external eHealth / Health Information projects with external partners. Currently, Bart was coordinator of the EMIF (European Medical Information Framework) project.